2013 annual financial data
Biodexa Pharmaceuticals 2013 Operating margin
Direct answer
Operating margin was -3,060.54%.
Operating income was -4,499,000 USD and net income was -4,084,000 USD.
Operating cash flow was -4,436,000 USD.
Get free Biodexa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 147,000 USD
- Operating income
- -4,499,000 USD
- Net income
- -4,084,000 USD
- Operating cash flow
- -4,436,000 USD